SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Repligen Corporation (RGEN) trades at a trailing P/E of 134.9, forward P/E of 65.8. Trailing earnings yield is 0.74%, forward earnings yield 1.52%. PEG 0.50 (Peter Lynch undervalued ≤1.0). Graham Number is $26.93.
Criteria proven by this page:
- VALUE (49/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 65.8 (down from trailing 134.9) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.50 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 0.74% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 1.52% as earnings recover.
- Analyst consensus target $183.00 (+39.7% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 61/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
49/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RGEN
Valuation Multiples
P/E (TTM)134.9
Forward P/E65.8
PEG Ratio0.50
Forward PEG0.50
P/B Ratio3.13
P/S Ratio8.90
EV/EBITDA37.9
Per Share Data
EPS (TTM)$0.87
Forward EPS (Est.)$1.99
Book Value / Share$37.26
Revenue / Share$13.06
FCF / Share$1.62
Yields & Fair Value
Earnings Yield0.74%
Forward Earnings Yield1.52%
Dividend Yield0.00%
Graham Number$26.93
SharesGrow IV$186.82 (+42.6%)
Analyst Target$183.00 (+39.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
88.6 |
3.54 |
6.13 |
9.90 |
- |
| 2017 |
48.9 |
0.44 |
2.34 |
9.82 |
- |
| 2018 |
138.9 |
-2.86 |
3.75 |
11.90 |
- |
| 2019 |
208.9 |
13.23 |
4.22 |
16.55 |
- |
| 2020 |
168.1 |
1.06 |
6.59 |
27.50 |
- |
| 2021 |
113.6 |
1.09 |
8.33 |
21.73 |
- |
| 2022 |
50.5 |
1.15 |
4.91 |
11.71 |
- |
| 2023 |
281.4 |
-3.48 |
5.10 |
15.84 |
- |
| 2024 |
-315.6 |
1.84 |
4.08 |
12.69 |
- |
| 2025 |
188.5 |
-0.65 |
4.38 |
12.48 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.34 |
$104.54M |
$11.68M |
11.2% |
| 2017 |
$0.72 |
$141.24M |
$28.35M |
20.1% |
| 2018 |
$0.37 |
$194.03M |
$16.62M |
8.6% |
| 2019 |
$0.44 |
$270.25M |
$21.41M |
7.9% |
| 2020 |
$1.11 |
$366.26M |
$59.93M |
16.4% |
| 2021 |
$2.24 |
$670.53M |
$128.29M |
19.1% |
| 2022 |
$3.24 |
$801.54M |
$185.96M |
23.2% |
| 2023 |
$0.63 |
$632.36M |
$35.6M |
5.6% |
| 2024 |
$-0.46 |
$634.44M |
$-25.51M |
-4% |
| 2025 |
$0.86 |
$738.26M |
$48.89M |
6.6% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.99 |
$1.97 – $2.02 |
$826.95M |
$816.61M – $834.66M |
11 |
| 2027 |
$2.53 |
$1.97 – $2.77 |
$947.81M |
$937.8M – $958.41M |
11 |
| 2028 |
$3.31 |
$2.66 – $3.81 |
$1.09B |
$1.09B – $1.1B |
5 |
| 2029 |
$4.47 |
$4.40 – $4.55 |
$1.28B |
$1.26B – $1.29B |
1 |
| 2030 |
$5.68 |
$5.58 – $5.77 |
$1.47B |
$1.46B – $1.49B |
1 |
